BRCA1-IN-2

CAS No. 1622262-55-8

BRCA1-IN-2( —— )

Catalog No. M32817 CAS No. 1622262-55-8

BRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 454 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRCA1-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    BRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.
  • Description
    BRCA1-IN-2 (compound 15) is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 with an IC50 of 0.31 μM and a Kd of 0.3 μM, which shows antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1622262-55-8
  • Formula Weight
    544.54
  • Molecular Formula
    C26H33N4O7P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (183.64 mM; Ultrasonic )
  • SMILES
    C(CC(N[C@H](C(NCC(NCCCCC1=CC=CC=C1)=O)=O)COP(=O)(O)O)=O)C=2C=3C(NC2)=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Na Z, et al. Protein-Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays. Methods Mol Biol. 2017;1518:139-156.?
molnova catalog
related products
  • Ac-tBu-Gly-tBu-Gly-A...

    Ac-tBu-Gly-tBu-Gly-Asn(Me)2-Ala-AMC

  • Agmatine sulfate sal...

    Agmatine sulfate is a bioactive metabolite of the arginine amino acid. It exerts modulatory action at multiple molecular targets such as neurotransmitter systems ion channels and nitric oxide synthesis. It is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor.

  • TBMP

    TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.